Aspirin for primary prevention of cardiovascular disease events.
about
A short-term effect of low-dose aspirin on major hemorrhagic risks in primary prevention: a case-crossover design.Cyclooxygenase inhibition does not alter methacholine-induced sweating.A short-term risk-benefit analysis of occasional and regular use of low-dose aspirin in primary prevention of vascular diseases: a nationwide population-based studyUse of aspirin for primary and secondary cardiovascular disease prevention in the United States, 2011-2012.The role of aspirin in the prevention of cardiovascular disease.Activation of activator protein 2 alpha by aspirin alleviates atherosclerotic plaque growth and instability in vivoEffectiveness of individual-focused interventions to prevent chronic disease.Aspirin dosing in cardiovascular disease prevention and management: an update.Proteome-wide prediction of targets for aspirin: new insight into the molecular mechanism of aspirin.Pharmacological evaluation and preparation of nonsteroidal anti-inflammatory drugs containing an N-acyl hydrazone subunit.Evidence for cyclooxygenase-dependent sweating in young males during intermittent exercise in the heat.A long-term risk-benefit analysis of low-dose aspirin in primary prevention.
P2860
Q33690112-54184E36-F216-404A-87F6-A34CD688D2BBQ34440160-135991D3-BDE4-4E90-9CFA-C4352422F486Q34903466-A46CBF56-6647-4F20-AE73-AB5D90ECCACDQ35026319-D08413DF-8F87-4D9E-AFEA-8310C4EA15F2Q35049359-BFC52C0B-F8D7-4CD8-82C9-2A5781689373Q37619656-2B0395AD-ABC4-4B77-BF83-792E2DC12E26Q38231641-C5F303FD-F603-4F3D-80D6-3BBDCDBC01F2Q38577514-AD395D03-8F97-4F80-8F2A-DBE59B39A51FQ39028044-676FA077-511E-43B6-810E-66720B8787AFQ39356641-6167C3D9-4570-4863-964D-B9D8B8AA5FEAQ40186404-51B2B3D7-9AD9-4E81-8847-8428F8BF8E9AQ41071461-ECCE2ECF-8EC4-49C2-B577-02DCF7F12B6C
P2860
Aspirin for primary prevention of cardiovascular disease events.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Aspirin for primary prevention of cardiovascular disease events.
@en
type
label
Aspirin for primary prevention of cardiovascular disease events.
@en
prefLabel
Aspirin for primary prevention of cardiovascular disease events.
@en
P2093
P2860
P356
P1433
P1476
Aspirin for primary prevention of cardiovascular disease events.
@en
P2093
Carrie W Nemerovski
Francine D Salinitri
Kathryn A Morbitzer
Lynette R Moser
P2860
P304
P356
10.1002/PHAR.1127
P407
P577
2012-09-27T00:00:00Z